In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues [+] | 16.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 13.4 | 9.6 |
Royalties | | | | | 50.6 | 29.3 | 13.4 | 9.6 |
Net investment income | | | | | | 0.2 | | |
Revenue growth | | | | | -100.0% | -98.4% | 40.4% | 156.1% |
Cost of goods sold | 8.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 26.8 | 19.1 |
Gross profit | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.4 | -9.6 |
Gross margin | 47.6% | | | | | 0.0% | -100.0% | -100.0% |
Selling, general and administrative [+] | 181.9 | 58.2 | 21.8 | 11.0 | 11.7 | 7.9 | 6.7 | 6.6 |
General and administrative | | | | | | 7.9 | 6.7 | 6.6 |
Research and development | 48.3 | 87.1 | 78.0 | 83.3 | 50.6 | 29.3 | | |
EBITDA [+] | -222.0 | -145.1 | -99.7 | -94.2 | -62.3 | -37.2 | -20.2 | -16.1 |
EBITDA growth | 53.1% | 45.5% | 5.8% | 51.2% | 67.2% | 84.7% | 25.1% | 96.6% |
EBITDA margin | -1320.1% | | | | | -17079.4% | -150.2% | -168.6% |
Depreciation and amortization | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
EBIT [+] | -222.2 | -145.3 | -99.8 | -94.3 | -62.3 | -37.2 | -20.2 | -16.1 |
EBIT growth | 52.9% | 45.5% | 5.9% | 51.3% | 67.3% | 84.7% | 25.1% | 96.6% |
EBIT margin | -1321.0% | | | | | -17080.3% | -150.3% | -168.6% |
Non-recurring items [+] | | | | | | 1.0 | | |
In-process research & development | | | | | | 1.0 | | |
Interest expense, net [+] | 5.3 | 13.4 | 17.3 | | | | -0.1 | -0.1 |
Interest expense | 5.3 | 13.4 | 17.3 | | | | 0.0 | |
Interest income | | | | | | | 0.1 | 0.1 |
Other income (expense), net [+] | 3.1 | -39.9 | -0.4 | -1.4 | 0.2 | -1.2 | 5.6 | 0.8 |
Gain (loss) on debt retirement | -1.2 | | | | | | | |
Unrealized gain/loss on derivatives | 4.3 | 0.1 | -0.4 | 1.4 | 0.1 | -1.9 | | |
Other non-operating income | | 0.1 | | | | 0.5 | | |
Other | | -0.1 | | 0.1 | 0.2 | 0.5 | -0.4 | 0.5 |
Pre-tax income | -224.3 | -198.6 | -117.5 | -95.7 | -62.1 | -39.4 | -14.5 | -15.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -224.3 | -198.6 | -117.5 | -95.7 | -62.1 | -39.4 | -14.5 | -15.2 |
Net margin | -1333.8% | | | | | -18093.6% | -107.8% | -159.2% |
|
Basic EPS [+] | ($1.00) | ($1.21) | ($1.11) | ($1.02) | ($0.73) | ($0.64) | ($0.30) | ($0.34) |
Growth | -17.6% | 8.5% | 9.6% | 39.3% | 14.0% | 110.3% | -10.4% | 53.0% |
Diluted EPS [+] | ($1.00) | ($1.21) | ($1.11) | ($1.02) | ($0.73) | ($0.64) | ($0.30) | ($0.34) |
Growth | -17.6% | 8.5% | 9.6% | 39.3% | 14.0% | 110.3% | -10.4% | 53.0% |
|
Shares outstanding (basic) [+] | 225.4 | 164.4 | 105.6 | 94.3 | 85.2 | 61.7 | 47.6 | 44.9 |
Growth | 37.1% | 55.8% | 12.0% | 10.6% | 38.1% | 29.6% | 6.1% | 22.5% |
Shares outstanding (diluted) [+] | 225.4 | 164.4 | 105.6 | 94.3 | 85.2 | 61.7 | 47.6 | 44.9 |
Growth | 37.1% | 55.8% | 12.0% | 10.6% | 38.1% | 29.6% | 6.1% | 22.5% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |